MAPT and Brain atrophy: In agreement with the CSF studies that showed that concomitant abnormalities in Aβ42/40 ratio and t-tau were detrimental to cognitive decline and brain atrophy, the plasma p-tau+/BD-tau+ and the p-tau+/BD-tau- cases had much steeper longitudinal cognitive decline and atrophy profiles.